γ-Tocopherol, but not α-tocopherol, potently inhibits neointimal formation induced by vascular injury in insulin resistant rats

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 3, 2006, Pages 544-554

  Takahashi, Katsuaki ^a   Komaru, Tatsuya ^a   Takeda, Satoru ^a   Takeda, Morihiko ^a   Koshida, Ryoji ^a   Nakayama, Masaharu ^a   Kokusho, Yasunori ^a   Kawakami, Yuki ^b   Yamaguchi, Nobuhiro ^a   Miyazawa, Teruo ^b   Shimokawa, Hiroaki ^a   Shirato, Kunio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Antioxidant; Carotid artery; Insulin resistance; Intima thickening; Nitrosative stress; Oxidative stress; Vascular injury; Vascular remodeling; Vascular smooth muscle; Vitamin E

Indexed keywords

3 NITROTYROSINE; ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; HYDROETHIDINE; HYDROPEROXIDE; PHOSPHATIDYLCHOLINE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CAROTID ARTERY INJURY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; GENE EXPRESSION; GLUCOSE INTAKE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ACRIDINES; ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; GAMMA-TOCOPHEROL; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA; TYROSINE; VASCULAR DISEASES; VITAMIN E;

EID: 33748427769     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.06.010     Document Type: Article

References (37)

1. Shinozaki K., Nishio Y., Okamura T., Yoshida Y., Maegawa H., Kojima H., et al. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ. Res. 87 (2000) 566-573
2. Takagi T., Yoshida K., Akasaka T., Kaji S., Kawamoto T., Honda Y., et al. Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study. J. Am. Coll. Cardiol. 36 (2000) 731-738
3. Azevedo L.C., Pedro M.A., Souza L.C., de Souza H.P., Janiszewski M., da Luz P.L., et al. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc. Res. 47 (2000) 436-445
4. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., and Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361 (2003) 2017-2023
5. Yusuf S., Dagenais G., Pogue J., Bosch J., and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342 (2000) 154-160
6. Wagner K.H., Kamal-Eldin A., and Elmadfa I. Gamma-tocopherol-An underestimated vitamin?. Ann. Nutr. Metab. 48 (2004) 169-188
7. Leonard S.W., Paterson E., Atkinson J.K., Ramakrishnan R., Cross C.E., and Traber M.G. Studies in humans using deuterium-labeled alpha- and gamma-tocopherols demonstrate faster plasma gamma-tocopherol disappearance and greater gamma-metabolite production. Free Radic. Biol. Med. 38 (2005) 857-866
8. Jiang Q., Elson-Schwab I., Courtemanche C., and Ames B.N. Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11494-11499
9. Gysin R., Azzi A., and Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 16 (2002) 1952-1954
10. Clowes A.W., Reidy M.A., and Clowes M.M. Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49 (1983) 327-333
11. Lee H.J., Choi S.S., Park M.K., An Y.J., Seo S.Y., Kim M.C., et al. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem. Biophys. Res. Commun. 296 (2002) 293-299
12. Danenberg H.D., Fishbein I., Gao J., Monkkonen J., Reich R., Gati I., et al. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 106 (2002) 599-605
13. Miyazawa T., Suzuki T., Fujimoto K., and Yasuda K. Chemiluminescent simultaneous determination of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide in the liver and brain of the rat. J. Lipid Res. 33 (1992) 1051-1059
14. Folch J., Lees M., Sloane G., and Stanley H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
15. Miyazawa T., Fujimoto K., Suzuki T., and Yasuda K. Determination of phospholipid hydroperoxides using luminol chemiluminescence-high-performance liquid chromatography. Methods Enzymol. 233 (1994) 324-332
16. Ueda T., and Igarashi O. New solvent system for extraction of tocopherols from biological specimens for HPLC determination and the evaluation of 2,2,5,7,8-pentamethyl-6-chromanol as an internal standard. J. Micronutr. Anal. 3 (1987) 185-198
17. Miller Jr. F.J., Gutterman D.D., Rios C.D., Heistad D.D., and Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82 (1998) 1298-1305
18. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91 (1993) 2546-2551
19. Hwang I.S., Ho H., Hoffman B.B., and Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10 (1987) 512-516
20. Laight D.W., Desai K.M., Gopaul N.K., Anggard E.E., and Carrier M.J. F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Eur. J. Pharmacol. 377 (1999) 89-92
21. Micheletta F., Natoli S., Misuraca M., Sbarigia E., Diczfalusy U., and Iuliano L. Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 136-140
22. Danenberg H.D., Welt F.G., Walker III M., Seifert P., Toegel G.S., and Edelman E.R. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 105 (2002) 2917-2922
23. Park S.J., Kim H.S., Yang H.M., Park K.W., Youn S.W., Jeon S.I., et al. Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 885-891
24. Christen S., Woodall A.A., Shigenaga M.K., Southwell-Keely P.T., Duncan M.W., and Ames B.N. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3217-3222
25. Cooney R.V., Franke A.A., Harwood P.J., Hatch-Pigott V., Custer L.J., and Mordan L.J. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1771-1775
26. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272 (1997) 1433-1436
27. Jiang Q., Lykkesfeldt J., Shigenaga M.K., Shigeno E.T., Christen S., and Ames B.N. Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic. Biol. Med. 33 (2002) 1534-1542
28. Dzau V.J., Braun-Dullaeus R.C., and Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8 (2002) 1249-1256
29. Yang Z.Y., Simari R.D., Perkins N.D., San H., Gordon D., Nabel G.J., et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 7905-7910
30. Yonemitsu Y., Kaneda Y., Tanaka S., Nakashima Y., Komori K., Sugimachi K., et al. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ. Res. 82 (1998) 147-156
31. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., et al. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409 (1997) 105-108
32. Saldeen T., Li D., and Mehta J.L. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J. Am. Coll. Cardiol. 34 (1999) 1208-1215
33. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
34. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., and Azzi A. d-Alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 12190-12194
35. Lafont A.M., Chai Y.C., Cornhill J.F., Whitlow P.L., Howe P.H., Chisolm G.M., et al. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J. Clin. Invest. 95 (1995) 1018-1025
36. Upston J.M., Witting P.K., Brown A.J., Stocker R., and Keaney Jr. J.F. Effect of vitamin E on aortic lipid oxidation and intimal proliferation after arterial injury in cholesterol-fed rabbits. Free Radic. Biol. Med. 31 (2001) 1245-1253
37. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., and Bostick R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med. 334 (1996) 1156-1162